View of Balancing Efficacy and Infection Risk: Low Dose Rituximab in Primary Autoimmune Hemolytic Anaemia

Return to Article Details Balancing Efficacy and Infection Risk: Low Dose Rituximab in Primary Autoimmune Hemolytic Anaemia Download Download PDF